Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Mantle Cell Lymphoma

Breast Cancer

Gastrointestinal Cancer

Mantle Cell Lymphoma

Expert Explains Latest Advances in Hodgkin Lymphoma, MCL

Chaitra S. Ujjani, MD, discusses the latest progress in both Hodgkin lymphoma and mantle cell lymphoma.
Read More >>

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies

BTK Inhibitors: Real-World Insights on Patient Management and Therapy Selection

The Changing Treatment Landscape in MCL and CLL: A Review of Standards of Care

Expert Predicts Promising Regimens Ahead in MCL

Asymptomatic, Young Patients With MCL May Avoid Active Treatment

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

2018 Lynn Sage Breast Cancer Symposium

Dr. Shah on Challenges of CAR T-Cell Clinical Trials in MCL

$Dr. Wang Discusses the Treatment of Relapsed/Refractory MCL$

Dr. Wang Discusses the Treatment of Relapsed/Refractory MCL

Dr. Cohen Discusses Combination Therapy in MCL

Dr. Kaplan on the Combination of Ibrutinib and Venetoclax in MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Highlights from ASH 2017: Mantle Cell Lymphoma

Investigational Treatment in Mantle Cell Lymphoma

Future Therapy: Bruton's TKI Containing Combinations in MCL

Allogeneic Transplantation in Mantle Cell Lymphoma

Acalabrutinib in Relapsed Mantle Cell Lymphoma

Ibrutinib in Relapsed Mantle Cell Lymphoma

Understanding Relapse in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

How to Properly Utilize MRD Testing

Emerging Agents for Mantle Cell Lymphoma

Acalabrutinib for Treating Mantle Cell Lymphoma

Ongoing Challenges in Treating Mantle Cell Lymphoma

$Treating Relapsed/Refractory Mantle Cell Lymphoma$

Role of Maintenance Therapy in Mantle Cell Lymphoma

Response Assessment in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Ibrutinib in Relapsed Mantle Cell Lymphoma

Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Treatments for Relapsed Mantle Cell Lymphoma

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

OncLive News Network On Location: 2018 ESMO Congress